NanoString Technologies Inc (OQ:NSTG)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
See Regulatory Filings on SEC
Company Contact
Address: 530 Fairview Ave N
SEATTLE WA 98109-5553
Tel: N/A
IR: See website
Key People
William D. Young
Independent Chairman of the Board
R. Bradley Gray
President, Chief Executive Officer, Director
K. Thomas Bailey
Chief Financial Officer
John Chad Brown
Senior Vice President - Sales and Marketing
Joseph M. Beechem
Senior Vice President - Research and Development
David W. Ghesquiere
Senior Vice President - Corporate and Business Development
Business Overview
NanoString Technologies, Inc. develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. The Company's nCounter Analysis System is an automated, multi-application, digital detection and counting system, which directly profiles hundreds of molecules simultaneously using a barcoding technology. The Company markets systems and related consumables to researchers in academic, government and biopharmaceutical laboratories for use in understanding fundamental biology and the molecular basis of diseases, such as cancer, and to clinical laboratories and medical centers for diagnostic use.
Financial Overview
For the nine months ended 30 September 2020,NanoString Technologies Inc revenues decreased 9% to$81.1M. Net loss increased 35% to $87.1M. Revenues reflecta decrease in demand for the Company's products andservices due to unfavorable market conditions. Higher netloss reflects Interest expense increase of 84% to $11.2M(expense), Interest income decrease of 28% to $1.5M(income).
Employees: 551 as of Dec 31, 2019
Reporting Currency: U.S. Dollars
Enterprise value: $3,024M as of Sep 30, 2020
Annual revenue (TTM): $117.99M as of Sep 30, 2020
EBITDA (TTM): -$86.10M as of Sep 30, 2020
Net annual income (TTM): -$63.09M as of Sep 30, 2020
Free cash flow (TTM): -$103.18M as of Sep 30, 2020
Net Debt Last Fiscal Year: N/A
Shares outstanding: 44,065,328 as of Nov 2, 2020
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.